×
About 1,436 results

ALLMedicine™ Calciphylaxis Center

Research & Reviews  695 results

Pain management in patients with end-stage renal disease and calciphylaxis- a survey of...
https://doi.org/10.1186/s12882-020-02067-2
BMC Nephrology; Chinnadurai R, Sinha S et. al.

Sep 19th, 2020 - Calciphylaxis is a rare condition usually seen in patients with end-stage renal disease. Pain is a hallmark of this condition and can be extremely difficult to control. Anecdotal data suggests that pain management in calciphylaxis is challenging w...

Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thios...
https://doi.org/10.1016/j.jaad.2020.07.090
Journal of the American Academy of Dermatology; Gabel CK, Nguyen ED et. al.

Jul 31st, 2020 - ● Calciphylaxis is a serious disorder with high morbidity and mortality and no approved therapy. Intralesional sodium thiosulfate (ILSTS) has not been well-studied as a treatment modality. ● This retrospective study identifies ILSTS as a potential...

Calciphylaxis-Associated Cutaneous Vascular Calcification in Noncalciphylaxis Patients.
https://doi.org/10.1097/DAD.0000000000001519
The American Journal of Dermatopathology; Chaudet KM, Dutta P et. al.

Jul 23rd, 2020 - Calciphylaxis is a highly morbid disease that is strongly associated with chronic kidney disease (CKD); however, the histologic criteria for diagnosis have not been well established nor have their specificity for calciphylaxis been determined. Thi...

Extracutaneous Manifestations of Calciphylaxis: Ogilvie's Syndrome With Perforation.
https://doi.org/10.1177/0003134820919736
The American Surgeon; Mitchell TA, Hoffer ZS et. al.

Jul 20th, 2020 - Calciphylaxis or calcific uremic arteriolopathy is a rare entity associated with the end-stage renal disease that presents with necrotic cutaneous lesions that may require surgical management. Extracutaneous manifestations of calciphylaxis includi...

Vascular calcification in skin and subcutaneous tissue in patients with chronic and end...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364566
BMC Nephrology; Ruderman I, Hewitson TD et. al.

Jul 17th, 2020 - Vascular calcification (VC) is well described in large- and medium-sized vessels in patients with chronic kidney disease (CKD), especially in those with end-stage kidney disease (ESKD) on dialysis. Medial calcification is particularly prevalent in...

see more →

Clinicaltrials.gov  707 results

Pain management in patients with end-stage renal disease and calciphylaxis- a survey of...
https://doi.org/10.1186/s12882-020-02067-2
BMC Nephrology; Chinnadurai R, Sinha S et. al.

Sep 19th, 2020 - Calciphylaxis is a rare condition usually seen in patients with end-stage renal disease. Pain is a hallmark of this condition and can be extremely difficult to control. Anecdotal data suggests that pain management in calciphylaxis is challenging w...

Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thios...
https://doi.org/10.1016/j.jaad.2020.07.090
Journal of the American Academy of Dermatology; Gabel CK, Nguyen ED et. al.

Jul 31st, 2020 - ● Calciphylaxis is a serious disorder with high morbidity and mortality and no approved therapy. Intralesional sodium thiosulfate (ILSTS) has not been well-studied as a treatment modality. ● This retrospective study identifies ILSTS as a potential...

Calciphylaxis-Associated Cutaneous Vascular Calcification in Noncalciphylaxis Patients.
https://doi.org/10.1097/DAD.0000000000001519
The American Journal of Dermatopathology; Chaudet KM, Dutta P et. al.

Jul 23rd, 2020 - Calciphylaxis is a highly morbid disease that is strongly associated with chronic kidney disease (CKD); however, the histologic criteria for diagnosis have not been well established nor have their specificity for calciphylaxis been determined. Thi...

Extracutaneous Manifestations of Calciphylaxis: Ogilvie's Syndrome With Perforation.
https://doi.org/10.1177/0003134820919736
The American Surgeon; Mitchell TA, Hoffer ZS et. al.

Jul 20th, 2020 - Calciphylaxis or calcific uremic arteriolopathy is a rare entity associated with the end-stage renal disease that presents with necrotic cutaneous lesions that may require surgical management. Extracutaneous manifestations of calciphylaxis includi...

Vascular calcification in skin and subcutaneous tissue in patients with chronic and end...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364566
BMC Nephrology; Ruderman I, Hewitson TD et. al.

Jul 17th, 2020 - Vascular calcification (VC) is well described in large- and medium-sized vessels in patients with chronic kidney disease (CKD), especially in those with end-stage kidney disease (ESKD) on dialysis. Medial calcification is particularly prevalent in...

see more →

News  27 results

An Unusual Presentation of Calciphylaxis
https://www.mdedge.com/dermatology/article/219998/rare-diseases/unusual-presentation-calciphylaxis/page/0/1?channel=44

Apr 1st, 2020 - The pathogenesis of calciphylaxis is not well understood; however, some researchers suggest that an imbalance in calcium-phosphate homeostasis may lead to calciphylaxis; that is, elevated calcium and phosphate levels exceed their solubility and de.

Nonuremic Calciphylaxis Triggered by Rapid Weight Loss and Hypotension
https://www.mdedge.com/dermatology/article/216159/mixed-topics/nonuremic-calciphylaxis-triggered-rapid-weight-loss-and/page/0/1?channel=45

Jan 27th, 2020 - Comment Background on Calciphylaxis Calciphylaxis is a rare but deadly disease that affects both ESRD patients receiving dialysis and patients without ESRD who have known risk factors for calciphylaxis, including female gender, white race, obesity.

Outpatient Management and Follow-up Recommendations for Adverse Drug Reactions: Guidelines for Posthospitalization Care
https://www.mdedge.com/dermatology/article/200161/mixed-topics/outpatient-management-and-follow-recommendations-adverse/page/0/1?channel=50892

May 3rd, 2019 - Long-term Sequelae Endocrine Thyroid gland abnormalities secondary to DRESS syndrome include Graves disease and Hashimoto disease as well as variations in biomarkers including elevated free thyroxine and low and elevated thyroid-stimulating hormon.

Update on Calciphylaxis Etiopathogenesis, Diagnosis, and Management
https://www.mdedge.com/dermatology/article/189412/wounds/update-calciphylaxis-etiopathogenesis-diagnosis-and-management/page/0/1

Nov 26th, 2018 - Prevention Reduction of the net calcium phosphorus product may help reduce the risk of calciphylaxis in ESRD patients, which can be accomplished by using non–calcium-phosphate binders, adequate dialysis, and restricting use of vitamin D and vitami.

see more →

Patient Education  7 results see all →